Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Inmune Bio (INMB) Shares Issued (2018 - 2025)

Inmune Bio (INMB) has disclosed Shares Issued for 7 consecutive years, with $18.9 million as the latest value for Q2 2025.

  • Quarterly Shares Issued changed N/A to $18.9 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was -$27.4 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $27.5 million for FY2025, 6427.01% up from the prior year.
  • Shares Issued hit $18.9 million in Q2 2025 for Inmune Bio, up from $1000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $18.9 million in Q2 2025 to a low of -$27.4 million in Q4 2024.
  • Historically, Shares Issued has averaged $578909.1 across 4 years, with a median of $669000.0 in 2022.
  • Biggest YoY gain for Shares Issued was 1385.54% in 2021; the steepest drop was 2341.27% in 2021.
  • Year by year, Shares Issued stood at $1.1 million in 2021, then plummeted by 40.11% to $669000.0 in 2022, then tumbled by 4190.73% to -$27.4 million in 2024, then skyrocketed by 169.06% to $18.9 million in 2025.
  • Business Quant data shows Shares Issued for INMB at $18.9 million in Q2 2025, $1000.0 in Q1 2025, and -$27.4 million in Q4 2024.